Literature DB >> 23146724

[Study of genetic susceptibility in 198 children with asthma].

Bo-Qiang Zheng1, Gui-Lan Wang, Sai Yang, Yan-Qiang Lu, Rui-Jun Liu, Ying Li.   

Abstract

OBJECTIVE: To analyze the frequency distribution of single nucleotide polymorphisms (SNPs) of four asthma-related gene loci (ACE I/D; ADRB2 Arg16Gly; TNF-α G-308A; MS4A2 Glu237Gly) in 198 asthmatic children, and to investigate its association with genetic susceptibility to childhood asthma and some clinical phenotypes of asthma.
METHODS: Polymerase chain reaction product electrophoresis identification and real-time quantitative PCR detecting system were used to determine the frequency distributions of the SNPs of the four asthma-related gene loci in 198 asthmatic children and 110 healthy controls. The serum total IgE (TIgE) levels and blood eosinophil proportion (%EOS) of the asthmatic children were measured. Different genotypes at the four asthma-related gene loci were compared in terms of TIgE and %EOS.
RESULTS: The genotype DD of angiotensin-converting enzyme (ACE) had a significantly higher frequency in the asthmatic children than in the healthy controls (χ2= 30.667, P<0.01), and the frequency of D allele was also significantly higher in the asthmatic children than in the healthy controls (χ2=7.151, P<0.01). No correlation was found between the polymorphism of each gene locus and serum TIgE level and %EOS (P>0.05).
CONCLUSIONS: Genotype DD of ACE is related to genetic susceptibility to childhood asthma and may be the risk factor for childhood asthma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23146724

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  9 in total

Review 1.  The Impact of ACE and ACE2 Gene Polymorphisms in Pulmonary Diseases Including COVID-19.

Authors:  Iphigenia Gintoni; Maria Adamopoulou; Christos Yapijakis
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

2.  Beta-2 adrenergic receptor (ADRB2) gene polymorphisms and the risk of asthma: a meta-analysis of case-control studies.

Authors:  Si-Qiao Liang; Xiao-Li Chen; Jing-Min Deng; Xuan Wei; Chen Gong; Zhang-Rong Chen; Zhi-Bo Wang
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

3.  Comments on 'Association of FcϵRIβ polymorphisms with risk of asthma and allergic rhinitis: evidence based on 29 case-control studies'.

Authors:  Haijun Yang; Lan Zheng; Yanmei Zhang; Min Yang; Sha Wei
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

4.  Association of FcεRIβ polymorphisms with risk of asthma and allergic rhinitis: evidence based on 29 case-control studies.

Authors:  Huanhuan Guo; Tao Peng; Ping Luo; Huabin Li; Shuo Huang; Shuang Li; Weidong Zhao; Xuhong Zhou
Journal:  Biosci Rep       Date:  2018-07-31       Impact factor: 3.976

5.  Association of β2-adrenergic receptor gene polymorphisms (rs1042713, rs1042714, rs1042711) with asthma risk: a systematic review and updated meta-analysis.

Authors:  Songlin Zhao; Wei Zhang; Xiuhong Nie
Journal:  BMC Pulm Med       Date:  2019-11-07       Impact factor: 3.317

6.  Angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to pediatric asthma: A meta-analysis.

Authors:  Zhengyang Shao; Haili Jin; Hong Sun; Chenxia Dong; Binbin Xu; Lu Zhan
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Apr-Jun       Impact factor: 1.636

7.  Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene as risk factors.

Authors:  Ana Carolina Zimiani de Paiva; Fernando Augusto de Lima Marson; José Dirceu Ribeiro; Carmen Sílvia Bertuzzo
Journal:  Allergy Asthma Clin Immunol       Date:  2014-02-05       Impact factor: 3.406

8.  Association between tumor necrosis factor-α rs1800629 polymorphism and risk of asthma: a meta-analysis.

Authors:  Guangdie Yang; Junjun Chen; Fei Xu; Zhang Bao; Yake Yao; Jianying Zhou
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

9.  Association between β2-adrenoceptor gene polymorphisms and asthma risk: an updated meta-analysis.

Authors:  Haojun Xie; Yuanxiong Cheng; Yating Huo; Guohua Huang; Jin Su
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.